Home・Listă Acțiuni・Novocure Ltd

Novocure Ltd

Închisă

SectorSănătate

16.3 3.95

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

15.68

Maxim

16.41

Indicatori cheie
By Trading Economics
Venit	55M -16M
Vânzări	9.5M 184M
EPS	-0.13
Marjă de profit	-8.529
Angajați	1,605
EBITDA	53M -11M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+88.02% upside

Dividende
By Acuity
Următoarele câștiguri	29 oct. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-62M 1.8B
Deschiderea anterioară	12.35
Închiderea anterioară	16.3

Sentimentul știrilor

By Acuity

55%

45%

277 / 340 Clasament în Healthcare

Novocure Ltd Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

6 aug. 2026, 19:36 UTC

Novocure Ltd. shares are trading lower, reaching a session low and remaining below the 20-day moving average during Thursday's trading session.

5 aug. 2026, 19:56 UTC

Novocure Ltd. shares are lower today, trading below their 20-day moving average and near the lower end of their one-month range.

4 aug. 2026, 21:02 UTC

Novocure Ltd. shares are lower in after-market trading, continuing a decline since Tuesday's close amid broader market volatility and fluctuating crude oil prices.

3 aug. 2026, 20:06 UTC

Novocure Ltd. shares are higher today, reflecting broader market gains amid positive investor sentiment and declines in oil prices.

31 iul. 2026, 19:46 UTC

Novocure Ltd. shares are lower today, retracing from earlier session highs amid rising bond yields and ongoing inflation concerns. The stock remains below its 20-day moving average.

30 iul. 2026, 19:39 UTC

Novocure Ltd shares are higher today, recovering from an early dip. The stock remains below its 20-day moving average amid a trend of lower closes.

29 iul. 2026, 18:55 UTC

Novocure Ltd's shares are declining today, reversing from a recent trend of higher daily closes. Earlier in the session, the stock briefly rebounded.

28 iul. 2026, 23:31 UTC

Novocure Ltd. shares are lower in after-market hours, continuing a decline over the past four sessions and trading below the 20-day moving average.

27 iul. 2026, 19:06 UTC

Novocure Ltd. shares are lower today amid a broader market decline influenced by a significant drop in crude oil prices.

24 iul. 2026, 19:41 UTC

News

Social Media

Novocure Ltd's stock is lower following its Q2 earnings report, despite a narrower loss and revenue beat. Analysts lowered price targets amid ongoing investor concerns.

22 iul. 2026, 20:04 UTC

Shares of Novocure Ltd. are lower today, continuing a decline since Tuesday's close amid broader market uncertainty ahead of the Federal Reserve meeting.

20 iul. 2026, 14:36 UTC

Novocure Ltd. is trading higher since Friday's close, despite pulling back from an early session high amid broader market volatility from geopolitical tensions.

Comparație

Modificare preț

Novocure Ltd Așteptări

Obiectiv de preț

By TipRanks

88.02% sus

Prognoză pe 12 luni

Medie 29.5 USD 88.02%

Maxim 52 USD

Minim 17 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruNovocure Ltd - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

4 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 4 analiști care au acordat evaluări ale acțiunilor Novocure Ltd - Dist în ultimele 3 luni.

Sentiment

By Acuity

277 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.